Actively Recruiting
Evaluation of ProLife 10 FORTE on Gut Microbiota Composition in UC Patients
Led by University of Padova · Updated on 2024-10-15
70
Participants Needed
1
Research Sites
108 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This clinical trial aims to learn if the probiotic Prolife 10 Forte could improve the Gut Microbiota composition of Ulcerative colitis patients during the remission phase. The main questions it seeks to answer are: * Does Prolife 10 Forte improve the microbiota composition in patients with Ulcerative colitis? * Is it possible to highlight the variation in microbial pathways? * What clinical parameters vary and are associated with changes in the gut microbiota? Researchers will compare Prolife 10 Forte to a placebo (a look-alike substance containing no drug) to see if the probiotics improve microbiota. Participants will: * Take 1 vial/day of Prolife 10 Forte /Placebo for 60 days. * Visit the clinic two times for checkups, Questionaire and tests
CONDITIONS
Official Title
Evaluation of ProLife 10 FORTE on Gut Microbiota Composition in UC Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of Ulcerative Colitis confirmed by clinical, endoscopic, and histopathological evidence with disease in remission phase
- Age between 18 and 75 years old
- Ability to participate fully in all aspects of this clinical trial
You will not qualify if you...
- Active Ulcerative Colitis confirmed by clinical, endoscopic, and histopathological evidence
- Diagnosis of Crohn's Disease, indeterminate colitis, ischemic colitis, radiation colitis, diverticular disease associated with colitis, or microscopic colitis
- Positive stool culture for active Clostridium difficile
- Pregnant women
- Allergy to soy or fructose
- Use of antibiotics or probiotics within 10 days before the first visit
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Edoardo Vincenzo Savarino
Padua, Padua, Italy, 35128
Actively Recruiting
Research Team
E
Edoardo V. Savarino, Prof.MD; PhD
CONTACT
S
Sonia Facchin, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here